Effects of the Mediterranean Diet or Nut Consumption On Gut Microbiota Composition and Fecal Metabolites and their Relationship With Cardiometabolic Risk Factors.

J. Muralidharan,J. Basora,David Garcia,M. Bulló,Alessandro Atzeni,Pierre Arcelín,Antoni Palau-Galindo,Jesús-García Gavilán,C. Papandreou,L. Camacho-Barcía,Serena Galié,A. Arias-Vásquez
DOI: https://doi.org/10.1002/mnfr.202000982
IF: 6.5749
2021-07-31
Molecular Nutrition & Food Research
Abstract:SCOPE To examine whether a Mediterranean Diet (MedDiet) compared to the consumption of nuts in the context of a habitual non-MedDiet exerts a greater beneficial effect on gut microbiota and fecal metabolites, thus contributing to explain major benefits on cardiometabolic risk factors. METHODS AND RESULTS Fifty adults with Metabolic Syndrome were randomized to a controlled, crossover 2-months dietary-intervention trial with a 1-month wash-out period, following a MedDiet or consuming nuts (50 g/day). Microbiota composition was assessed by 16S rRNA gene sequencing and metabolites were measured using NMR and LC-qTOF platforms in a targeted metabolomics approach. Decreased glucose, insulin and HOMA-IR was observed after the MedDiet compared to the nuts intervention. Relative abundances of Lachnospiraceae NK4A136 and un uncultured genera of Ruminococcaceae were significantly increased after the MedDiet compared to nuts supplementation. Changes in Lachnospiraceae NK4A136 were inversely associated with insulin levels and HOMA-IR, while positively and negatively with changes in cholate and cadaverine, respectively. CONCLUSIONS Following a MedDiet, rather than nuts, induced a significant increase in Lachnospiraceae NK4A136 and improved the metabolic risk. This genera seems to affect the bile acid metabolism and cadaverine which may account for the improvement in insulin levels. This article is protected by copyright. All rights reserved.
Medicine,Environmental Science
What problem does this paper attempt to address?